| Turquia | Áustria | Espanha | |
| Hemipelvectomia | de $34,000 | de $28,500 | de $28,500 |
A Bookimed não adiciona taxas extras aos preços de Hemipelvectomia. As tarifas vêm das listas oficiais das clínicas. O pagamento é feito diretamente na clínica na chegada.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais em Hemipelvectomia e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de Hemipelvectomia.
O Dr. Solak é especialista no tratamento de cancros complexos, como o cancro da mama, testicular e gastrointestinal, no Hospital Hisar Intercontinental.
Dr. Cem Yalcinkaya is an associate professor and gynecologic oncologist at Anadolu Medical Center. He specializes in fertility-sparing surgeries and robotic procedures for gynecologic cancers. Dr. Yalcinkaya holds a robotic surgeon certificate for the DaVinci system. He successfully passed the European Society of Gynecologic Oncology (ESGO) exam in 2019.
Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.
Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.
Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.
He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.